Cargando…
A de novo MAPRE2 variant in a patient with congenital symmetric circumferential skin creases type 2
BACKGROUND: Congenital symmetric circumferential skin creases (CSCSC) was initially described five decades ago. Exome sequencing has recently revealed the genetic etiology of CSCSC. Pathogenic variants in TUBB (OMIM# 191130) and MAPRE2 (OMIM# 605789) have been linked to CSCSC1 (OMIM# 156610) and CSC...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005612/ https://www.ncbi.nlm.nih.gov/pubmed/31903734 http://dx.doi.org/10.1002/mgg3.1096 |
_version_ | 1783494973573824512 |
---|---|
author | Feng, Jincai Lan, Xiaoping Shen, Jun Song, Xiaozhen Tang, Xiaojun Xu, Wuhen Ren, Xiang Zhang, Hong Yu, Guangjun Wu, Shengnan |
author_facet | Feng, Jincai Lan, Xiaoping Shen, Jun Song, Xiaozhen Tang, Xiaojun Xu, Wuhen Ren, Xiang Zhang, Hong Yu, Guangjun Wu, Shengnan |
author_sort | Feng, Jincai |
collection | PubMed |
description | BACKGROUND: Congenital symmetric circumferential skin creases (CSCSC) was initially described five decades ago. Exome sequencing has recently revealed the genetic etiology of CSCSC. Pathogenic variants in TUBB (OMIM# 191130) and MAPRE2 (OMIM# 605789) have been linked to CSCSC1 (OMIM# 156610) and CSCSC2 (OMIM# 616734), respectively, in an autosomal dominant manner. Four pathogenic variants in MAPRE2 have been previously reported to be associated with CSCSC2. METHODS: Whole‐exome sequencing (WES) has been performed and an in‐house pipeline was used to conduct a phenotype‐driven data analysis. All candidate variants were confirmed by Sanger sequencing. RESULTS: Here we report a 2‐year‐old boy characterized by absent expressive speech, normal to mild over growth, facial dysmorphic features, remarkable circumferential skin creases on both forearms and ankles. WES disclosed a de novo missense MAPRE2 variant, c.518G>A (p.Arg173Gln), as the molecular cause of this complex phenotype. We described detailed clinical characterization of this patient and compared the available clinical data of individuals with MAPRE2 variants to demonstrate the phenotypic spectrum. CONCLUSION: Our study reports the first patient of Asian origin with CSCSC2 due to a pathogenic mutation of MAPRE2 and expands the clinical and genetic spectrum of CSCSC2. |
format | Online Article Text |
id | pubmed-7005612 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-70056122020-02-13 A de novo MAPRE2 variant in a patient with congenital symmetric circumferential skin creases type 2 Feng, Jincai Lan, Xiaoping Shen, Jun Song, Xiaozhen Tang, Xiaojun Xu, Wuhen Ren, Xiang Zhang, Hong Yu, Guangjun Wu, Shengnan Mol Genet Genomic Med Original Articles BACKGROUND: Congenital symmetric circumferential skin creases (CSCSC) was initially described five decades ago. Exome sequencing has recently revealed the genetic etiology of CSCSC. Pathogenic variants in TUBB (OMIM# 191130) and MAPRE2 (OMIM# 605789) have been linked to CSCSC1 (OMIM# 156610) and CSCSC2 (OMIM# 616734), respectively, in an autosomal dominant manner. Four pathogenic variants in MAPRE2 have been previously reported to be associated with CSCSC2. METHODS: Whole‐exome sequencing (WES) has been performed and an in‐house pipeline was used to conduct a phenotype‐driven data analysis. All candidate variants were confirmed by Sanger sequencing. RESULTS: Here we report a 2‐year‐old boy characterized by absent expressive speech, normal to mild over growth, facial dysmorphic features, remarkable circumferential skin creases on both forearms and ankles. WES disclosed a de novo missense MAPRE2 variant, c.518G>A (p.Arg173Gln), as the molecular cause of this complex phenotype. We described detailed clinical characterization of this patient and compared the available clinical data of individuals with MAPRE2 variants to demonstrate the phenotypic spectrum. CONCLUSION: Our study reports the first patient of Asian origin with CSCSC2 due to a pathogenic mutation of MAPRE2 and expands the clinical and genetic spectrum of CSCSC2. John Wiley and Sons Inc. 2020-01-05 /pmc/articles/PMC7005612/ /pubmed/31903734 http://dx.doi.org/10.1002/mgg3.1096 Text en © 2019 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Feng, Jincai Lan, Xiaoping Shen, Jun Song, Xiaozhen Tang, Xiaojun Xu, Wuhen Ren, Xiang Zhang, Hong Yu, Guangjun Wu, Shengnan A de novo MAPRE2 variant in a patient with congenital symmetric circumferential skin creases type 2 |
title | A de novo MAPRE2 variant in a patient with congenital symmetric circumferential skin creases type 2 |
title_full | A de novo MAPRE2 variant in a patient with congenital symmetric circumferential skin creases type 2 |
title_fullStr | A de novo MAPRE2 variant in a patient with congenital symmetric circumferential skin creases type 2 |
title_full_unstemmed | A de novo MAPRE2 variant in a patient with congenital symmetric circumferential skin creases type 2 |
title_short | A de novo MAPRE2 variant in a patient with congenital symmetric circumferential skin creases type 2 |
title_sort | de novo mapre2 variant in a patient with congenital symmetric circumferential skin creases type 2 |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005612/ https://www.ncbi.nlm.nih.gov/pubmed/31903734 http://dx.doi.org/10.1002/mgg3.1096 |
work_keys_str_mv | AT fengjincai adenovomapre2variantinapatientwithcongenitalsymmetriccircumferentialskincreasestype2 AT lanxiaoping adenovomapre2variantinapatientwithcongenitalsymmetriccircumferentialskincreasestype2 AT shenjun adenovomapre2variantinapatientwithcongenitalsymmetriccircumferentialskincreasestype2 AT songxiaozhen adenovomapre2variantinapatientwithcongenitalsymmetriccircumferentialskincreasestype2 AT tangxiaojun adenovomapre2variantinapatientwithcongenitalsymmetriccircumferentialskincreasestype2 AT xuwuhen adenovomapre2variantinapatientwithcongenitalsymmetriccircumferentialskincreasestype2 AT renxiang adenovomapre2variantinapatientwithcongenitalsymmetriccircumferentialskincreasestype2 AT zhanghong adenovomapre2variantinapatientwithcongenitalsymmetriccircumferentialskincreasestype2 AT yuguangjun adenovomapre2variantinapatientwithcongenitalsymmetriccircumferentialskincreasestype2 AT wushengnan adenovomapre2variantinapatientwithcongenitalsymmetriccircumferentialskincreasestype2 AT fengjincai denovomapre2variantinapatientwithcongenitalsymmetriccircumferentialskincreasestype2 AT lanxiaoping denovomapre2variantinapatientwithcongenitalsymmetriccircumferentialskincreasestype2 AT shenjun denovomapre2variantinapatientwithcongenitalsymmetriccircumferentialskincreasestype2 AT songxiaozhen denovomapre2variantinapatientwithcongenitalsymmetriccircumferentialskincreasestype2 AT tangxiaojun denovomapre2variantinapatientwithcongenitalsymmetriccircumferentialskincreasestype2 AT xuwuhen denovomapre2variantinapatientwithcongenitalsymmetriccircumferentialskincreasestype2 AT renxiang denovomapre2variantinapatientwithcongenitalsymmetriccircumferentialskincreasestype2 AT zhanghong denovomapre2variantinapatientwithcongenitalsymmetriccircumferentialskincreasestype2 AT yuguangjun denovomapre2variantinapatientwithcongenitalsymmetriccircumferentialskincreasestype2 AT wushengnan denovomapre2variantinapatientwithcongenitalsymmetriccircumferentialskincreasestype2 |